Patents Represented by Attorney Gregory R. Bellomy

Find this attorney in the Justia Lawyer Directory

  • FDF-03 S1 antigen-antibody complex
    Patent number: 7932357
    Abstract: Nucleic acids encoding various monocyte-derived proteins and related compositions, including purified proteins and specific antibodies are described. Methods of using such composition are also provided.
    Type: Grant
    Filed: February 17, 2004
    Date of Patent: April 26, 2011
    Assignee: Schering Corporation
    Inventors: Elizabeth Bates, Nathalie Fournier, Lionel Chalus, Pierre Garrone
  • IL-D80 polypeptides and IL-27
    Patent number: 7906622
    Abstract: Purified genes encoding a cytokine or composite cytokine from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding these molecules are provided. Methods of using said reagents and diagnostic kits are also provided.
    Type: Grant
    Filed: March 30, 2009
    Date of Patent: March 15, 2011
    Assignee: Schering Corporation
    Inventors: Jacqueline C. Timans, Stefan Karl-Heinz Pflanz, Robert A. Kastelein, J. Fernando Bazan, Donna Rennick, Rene de Waal Malefyt, Jeanne Cheung
  • Agonist antibodies to IL-23 receptor
    Patent number: 7893215
    Abstract: Provided are methods of treatment for skin disorders. In particular, treatment, the skin disorders are generally inflammatory skin disorders, including improper wound healing. Provided are methods of using of a cytokine molecule.
    Type: Grant
    Filed: July 22, 2009
    Date of Patent: February 22, 2011
    Assignee: Schering Corporation
    Inventors: Edward P. Bowman, Shi-Juan Chen, Daniel J. Cua, Kevin W. Moore, Tatyana Churakova, Hong-Nhung Y. Nguyen, Jason R. Chan
  • Mammalian receptor proteins DCRS5; method of treatment
    Patent number: 7887806
    Abstract: Nucleic acids encoding mammalian, e.g., primate, receptors, purified receptor proteins and fragments thereof. Antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are described.
    Type: Grant
    Filed: July 12, 2010
    Date of Patent: February 15, 2011
    Assignee: Schering Corporation
    Inventors: Madaline Chirica, Robert A. Kastelein, Kevin Moore, Christi L. Parham
  • IL-12P40 and IL-B30 polypeptide complex
    Patent number: 7883695
    Abstract: Purified genes encoding cytokine from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding this molecule are provided. Methods of using said reagents and diagnostic kits are also provided.
    Type: Grant
    Filed: August 10, 2006
    Date of Patent: February 8, 2011
    Assignee: Schering Corporation
    Inventors: Birgit Oppmann, Rene de Waal Malefyt, Donna M. Rennick, Robert A. Kastelein, Maria T. Wiekowski, Sergio A. Lira, Satwant K. Narula
  • Treatment of diabetes using antibodies to IL-23, IL-23 receptor and IL-17
    Patent number: 7820168
    Abstract: The instant specification provides methods of treatment for inflammatory and autoimmune disorders of the metabolic system. The instant specification also provides methods of diagnosis.
    Type: Grant
    Filed: December 16, 2005
    Date of Patent: October 26, 2010
    Assignee: Schering Corporation
    Inventors: Daniel J. Cua, Robert A. Kastelein
  • Engineered anti-IL-23 antibodies
    Patent number: 7807160
    Abstract: Engineered antibodies to human IL-23p19 are provided, as well as uses thereof, e.g. in treatment of inflammatory, autoimmune, and proliferative disorders.
    Type: Grant
    Filed: August 29, 2006
    Date of Patent: October 5, 2010
    Assignee: Schering Corporation
    Inventors: Leonard G. Presta, Brian M. Beyer, Richard N. Ingram, Peter Orth, Yan-Hui Liu
  • Method of treating skin inflammation
    Patent number: 7776540
    Abstract: Provided are methods for diagnosing the propensity of a subject to develop skin inflammation, in particular, psoriasis. Also provided are methods of treatment with antagonists of IL-17 and/or IL-23.
    Type: Grant
    Filed: September 2, 2008
    Date of Patent: August 17, 2010
    Assignee: Schering Corporation
    Inventors: Robert A. Kastelein, Terrill K. McClanahan, Erin Murphy
  • Mammalian receptor protein DCRS5; methods of treatment
    Patent number: 7754214
    Abstract: Nucleic acids encoding mammalian, e.g., primate, receptors, purified receptor proteins and fragments thereof. Antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are described.
    Type: Grant
    Filed: July 28, 2008
    Date of Patent: July 13, 2010
    Assignee: Schering Corporation
    Inventors: Madaline Chirica, Robert A. Kastelein, Kevin W. Moore, Christi L. Parham
  • Method of treatment of skin inflammation
    Patent number: 7740848
    Abstract: Provided are methods for diagnosing the propensity of a subject to develop skin inflammation, in particular, psoriasis. Also provided are methods of treatment with antagonists of IL-17, IL-19, and/or IL-23.
    Type: Grant
    Filed: September 2, 2008
    Date of Patent: June 22, 2010
    Assignee: Schering Corporation
    Inventors: Robert A. Kastelein, Terrill K. McClanahan, Erin Murphy, Jason R. Chan